NASDAQ
Financial data for RNA
13.99% YoY
51.87% YoY
0.69% YoY
Annual Income Statement for RNA
| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $11M | $10M | $9M | $9M | $7M |
| Cost of Revenue | $0 | $2M | $1M | $101M | $38M |
| Gross Profit | $11M | $7M | $8M | -$92M | -$31M |
| Operating Expenses | $390M | $243M | $187M | $26M | $13M |
| Operating Income | -$379M | -$236M | -$179M | -$118M | -$44M |
| Net Income | -$322M | -$212M | -$174M | -$118M | -$44M |
| EPS | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 |
| EBITDA | -$376M | -$233M | -$178M | -$117M | -$44M |
No price data available for this timeframe.